Cargando…

Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy

Triple negative breast cancer (TNBC) cells express increased levels of the pro-inflammatory and pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8), which promotes their proliferation and migration. Because TNBC patients are unresponsive to current targeted therapies, new therapeutic strategies are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uddin, Mohammad M., Zou, Yue, Sharma, Tamanna, Gatla, Himavanth R., Vancurova, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082561/ https://www.ncbi.nlm.nih.gov/pubmed/30089134 http://dx.doi.org/10.1371/journal.pone.0201858

Ejemplares similares

HDAC/IKK inhibition therapies in solid tumors
por: Vancurova, Ivana, et al.
Publicado: (2017)

Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
por: Gatla, Himavanth R., et al.
Publicado: (2017)

IKK inhibition increases bortezomib effectiveness in ovarian cancer
por: Singha, Bipradeb, et al.
Publicado: (2015)

Transcriptional Regulation of Chemokine Expression in Ovarian Cancer
por: Singha, Bipradeb, et al.
Publicado: (2015)

IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
por: Thompson, Leslie Michels, et al.
Publicado: (2009)

IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL‐8 expression in ovarian cancer cells
por: Gaire, Bijaya, et al.
Publicado: (2023)

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
por: Prescott, Jack A., et al.
Publicado: (2018)

IKKα negatively regulates ASC-dependent inflammasome activation
por: Martin, Bradley N., et al.
Publicado: (2014)

Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
por: Gatla, Himavanth Reddy, et al.
Publicado: (2019)

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
por: Ram Makena, Monish, et al.
Publicado: (2019)

Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing
por: Gatla, Himavanth, et al.
Publicado: (2022)

Anti-inflammatory Actions of Endogenous and Exogenous Interleukin-10 versus Glucocorticoids on Macrophage Functions of the Newly Born
por: Kasat, Kavita, et al.
Publicado: (2014)

Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis
por: Parida, Sheetal, et al.
Publicado: (2023)

IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
por: Liao, Jian, et al.
Publicado: (2023)

Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
por: Hossain, Fokhrul, et al.
Publicado: (2018)

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
por: Raninga, Prahlad V., et al.
Publicado: (2020)

Context-Dependent Role of IKKβ in Cancer
por: Page, Angustias, et al.
Publicado: (2017)

Gene Expression Profile of Endotoxin-stimulated Leukocytes of the Term New Born: Control of Cytokine Gene Expression by Interleukin-10
por: Davidson, Dennis, et al.
Publicado: (2013)

Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence
por: Kolesnichenko, Marina, et al.
Publicado: (2021)

ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ
por: Zhang, Yu, et al.
Publicado: (2017)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

Metformin induces protein acetylation in cancer cells
por: Vancura, Ales, et al.
Publicado: (2017)

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
por: de Paula, Bruno, et al.
Publicado: (2023)

Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
por: Chapdelaine, Abygail G., et al.
Publicado: (2023)

Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer
por: Durand, Joel K., et al.
Publicado: (2018)

CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation
por: Liao, Yina, et al.
Publicado: (2020)

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
por: Chen, Yun-Ju, et al.
Publicado: (2013)

Skyldig! - Ikke skyldig! /
por: Coppee, François, 1842-1908. [from old catalog]
Publicado: (1898)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

IKKα and IKKβ Regulation of DNA Damage-Induced Cleavage of Huntingtin
por: Khoshnan, Ali, et al.
Publicado: (2009)

Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells
por: Kaur, Pritpal, et al.
Publicado: (2021)

Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells
por: Ho, Catherine M. K., et al.
Publicado: (2016)

Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation
por: Olivotto, Eleonora, et al.
Publicado: (2015)

IKKε inhibits PKC to promote Fascin-dependent actin bundling
por: Otani, Tetsuhisa, et al.
Publicado: (2016)

Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis
por: Menbari, Mohammad-Nazir, et al.
Publicado: (2020)

PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer
por: Wang, Xueyan, et al.
Publicado: (2022)

UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
por: Shoji, Yoshiaki, et al.
Publicado: (2022)

PSMB1 Negatively Regulates the Innate Antiviral Immunity by Facilitating Degradation of IKK-ε
por: Wu, Fangyi, et al.
Publicado: (2019)

The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε
por: He, Tian-Sheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usprk624fleo8oaik0i4j5hrgc